Fluicell: Funding, Investors & Team (Sep 2026)

Fluicell AB is one of the manufacturers of fluid platforms for multifunctional pipettes. Living tissues are composed of a heterogeneous population of individual cells, which can differ dramatically from each other. These differences can have important consequences for the health and propagation of the entire population. To better study disease and aid in drug development, an in-depth analysis of cell behavior and physiological responses can best be accomplished with single-cell data. Our mission is to redefine the approach to cell biology, and drug discovery by providing miniaturized instrumentation for single-cell investigations. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate. Fluicell counts to their roster some of the world´s most brilliant and influential scientists and innovators in the field. Our devices offer unprecedented data quality, throughput, resolution, and speed at affordable prices together with the capability to generate unique and critical data from single cells.

Fluicell has raised $20k across 1 round on record. The most recent is an undisclosed round of $20k announced in Oct 2024.

Fluicell's most recent funding round on record is an undisclosed round of $20k, announced in Oct 2024.

FundedIQ lists Gavin Dm Jeffries (Founder) at Fluicell.

Fluicell is based in Gothenburg, Vastra Gotaland, Sweden.

Fluicell is in the 11-50 employee band.

Fluicell's latest round of $20k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.